Israeli genomic analysis startup Genoox hopes to lower the barrier to entry for next-generation sequencing, making it accessible to non-academic centers.
Bioinformatics and genomic medicine stand to have outsize influence in the the new, university-wide Vanderbilt Data Science Visions Working Group.
The company is developing a bioinformatics platform that searches billions of molecules to generate a library of compounds to manipulate cell biology.
Telehealth startup PWNHealth will provide physician oversight services to Sema4's recently launched CarrierChek product, allowing for a nationwide rollout.
With this latest funding, the precision medicine company has raised $130 million to date.
The computational tools will be designed to screen DNA sequences to detect biological threats that may arise from synthetic microbial manipulation.
Verge is working with four academic institutions to create a broad resource for the translation of preclinical models of amyotrophic lateral sclerosis research.
Publishing house Hearst is pushing into precision medicine with a $75 million investment in M2Gen, the informatics subsidiary of Moffitt Cancer Center.
The company is preparing to launch its first product, an application for DNA sequencing alignment based on its high-performance computing processor technology.
An international team of researchers said their set of 80 SNPs could be used to uniquely identify and track personal genome samples.
After more than two years of development, the British vendor has matched HPC for sequencing alignment accuracy, at far lower power consumption.
Molecular Health will make its analysis tools available to aid in the interpretation of raw data generated by customers of Agena's MassArray system.
The companies have partnered to jointly offer products and services for cancer specimen research and clinical data analysis.
Additional studies and reanalyses can reclassify variants of unknown significance, speakers at the National Society of Genetic Counselors meeting said.
Tempus will provide molecular sequencing and data analysis for patients with metastatic or incurable cancer enrolled in a Cleveland Clinic study.
The firm now intends to set up an internal laboratory to experiment with different compounds, while building out its team.
The deal will join the AmbryPort 2.0 clinical ordering platform with FDNA's Face2Gene next-generation phenotyping application suite.
Swedish Cancer Institute has enlisted machine-learning technology vendor GNS Healthcare to model patient-specific breast cancer tumor data.
Enpicom will initially offer separate solutions on its ImmunoGenomiX platform for research and clinical applications in oncology but seeks to expand into other disease areas.
Swiss genomic analytics and AI firm Sophia Genetics has closed on a $30 million Series D round, led by new investor Balderton Capital.
New Mexico is re-doing its proposed science education standards after criticism, the Associated Press reports.
Agbio executives say gene editing will speed up breeding efforts, according to the Wall Street Journal.
La Trobe University's Jenny Graves has won the $250,000 Prime Minister's Prize for Science, the Guardian reports.
In Cell this week: post-treatment changes to melanoma genome, multi-omics analysis of muscle-invasive bladder cancer, and more.